维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Howden S E"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Good clinical outcomes but highrates of adverse reactions during linezolidtherapy for serious infections:A proposed protocol for monitoring therapy in complex patients显示文摘	Bishop E Melvani S Howden BP etal	2006	Antimicrob Agents Chemother2006，50，：	1
	2	Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients 显示文摘	BISHOP E MELVANI S HOWDEN BP	2006	Antimicrob Agents Chemother2006，50，4：	1
	3	Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients 显示文摘	Bishop E Melvani S Howden B P	2006	Antimicrob Agents Chemother2006，50，4：	1
	4	The glu-tathione-deficient, cadmium-sensitive mutant, cad2-1, of Arabidops thiana is deficient in T-glutamylcysteine synthetase显示文摘	Cobbett E S May M J Howden R	1998	Plant J1998，16，1：	1
	5	Good clinical out- comes but high rates of adverse reactions during linezolid therapy for serious infections:a proposed protocol for monito- ring therapy in complex patients显示文摘	Bishop E Melvani S Howden BP	2006	Antlmicrob Agents Che- mother2006，50，4：	1
	6	Good clinical out-comes but high rates of adverse reactions during linezolidtherapy for serious infections : a proposed protocol for moni-toring therapy in complex patients 显示文摘	Bishop E Melvani S Howden BP	2006	Antimicrob AgentsChemother2006，50，4：	1
	7	Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients 显示文摘	BISHOP E MELVANI S HOWDEN BP	2006	Antimicrob Agents Chemother2006，50，4：	1
	8	Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infec- tions: A proposed protocol for monitoring therapy in complex patients 显示文摘	Bishop E Melvani S Howden BP	2006	Antimicrob Agents Chemother2006，50，4：	1
	9	Optic vesicle-like structures derived from human pluripotent stem cells facilitate a cus-tomized approach to retinal disease treatment 显示文摘	Meyer J S Howden S E Wallace K A	2011	Stem Cells2011，29，8：	1
	10	Good clinical outcomes but high rates of adverse ructions during line- zolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients显示文摘	Bishop E Melvani S Howden BP	2006	Antimicrob Agents Chemother2006，50，4：	1
	11	Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections : a proposed protocol for monitoring therapy in complex patients 显示文摘	Bishop E Melvani S Howden BP	2006	Antimicrob Agents Chemother2006，50，4：	1
	12	Good clinical outcomes but highrates of adverse reactions during linezolid thera- py for serious infections: A proposed protocol for monitoring ther- apy in complex patients 显示文摘	BISHOP E MELVANI S HOWDEN BP	2006	Antimicrob Agents Chemother2006，50，4：	1
	13	Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infec- tions:a proposed protocol for monitoring therapy in complex patl,mtg 显示文摘	Bishop E Melvani S Howden BP	2006	Antimierob Agents Chemother2006，50，4：	1
	14	Good clinical outcomes but high rates of adverse reactions during li- nezolid therapy for serious infections:a proposed protocol for monitoring therapy in complex patients 显示文摘	Bishop E Melvani S Howden BP	2006	Antimi- crob Agents Chemother2006，50，4：	1
	15	Good clinical out- comes but highrates of adverse reactions during linezolidthera- py for serious infections:A proposed protocol for monitoring therapy in complex 显示文摘	Bishop E Melvani S Howden BP	2006	Antimicrob Antimicrob Agents Che- mother2006，50，4：	1
	16	Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients 显示文摘	Bishop E Melvani S Howden BP	2006	Antimicrob Agents Chemother2006，50，4：	1
	17	Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients 显示文摘	Bishop E Melvani S Howden BP	2006	Antimicrob Agents Chemother2006，50，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费